CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study.
Tomoyuki OtsukaSumiyuki NishidaTakayuki ShibaharaBurcu TemizozMasanari HamaguchiTakayuki ShiroyamaKeiko KimuraKotaro MiyakeHaruhiko HirataYumiko MizunoMayu YagitaYusuke ManabeEtsushi KurodaYoshito TakedaHiroshi KidaKen J IshiiAtsushi KumanogohPublished in: BMC cancer (2022)
UMIN-CTR number 000023276. Registered 1 September 2016, https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000026649.